# A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

> **NCT07336446** · PHASE1,PHASE2 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 300 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** AZD9750
- **DRUG:** AZD5305

## Key facts

- **NCT ID:** NCT07336446
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-27
- **Primary completion:** 2029-01-26
- **Final completion:** 2029-01-26
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07336446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07336446, "A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07336446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*